- Q1 2024 Merck KGaA Earnings Call TranscriptMay 15, 2024€165.78 (+4.47%)Earnings
- Q4 2023 Merck KGaA Earnings Press Conference TranscriptMar 07, 2024
- Merck KGaA at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Q3 2023 Merck KGaA Earnings Call TranscriptNov 09, 2023€153.83 (+3.52%)Earnings
- Merck KGaA Capital Markets Day TranscriptOct 19, 2023
- Q2 2023 Merck KGaA Earnings Call TranscriptAug 03, 2023€163.78 (+3.26%)Earnings
- Q2 2023 Merck KGaA Earnings Press Conference TranscriptAug 03, 2023
- Q1 2023 Merck KGaA Earnings Call TranscriptMay 11, 2023€165.65 (+2.79%)Earnings
- Merck KGaA Annual Shareholders Meeting TranscriptApr 28, 2023
- Q4 2022 Merck KGaA Earnings Call TranscriptMar 02, 2023€179.83 (+1.64%)Earnings
- Merck KGaA at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Merck KGaA R&D Update Call TranscriptNov 21, 2022
- Q3 2022 Merck KGaA Earnings Call TranscriptNov 10, 2022€177.43 (+3.83%)Earnings
- Merck KGaA Capital Markets Day TranscriptOct 06, 2022
- Q2 2022 Merck KGaA Earnings Call TranscriptAug 04, 2022€184.88 (+0.56%)Earnings
- Q1 2022 Merck KGaA Earnings Call TranscriptMay 12, 2022€160.73 (-5.15%)Earnings
- Merck KGaA Annual Shareholders Meeting TranscriptApr 22, 2022
- Full Year 2021 Merck KGaA Earnings Call TranscriptMar 03, 2022€176.35 (+0.99%)Earnings
- Merck KGaA at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Merck KGaA R&D Update Call TranscriptNov 22, 2021
- Q3 2021 Merck KGaA Earnings Call TranscriptNov 11, 2021€205.5 (-0.36%)Earnings
- Merck KGaA Capital Markets Day (Virtual) TranscriptSep 09, 2021
- Half Year 2021 Merck KGaA Earnings Call TranscriptAug 05, 2021€188.03 (+6.56%)Earnings
- Q1 2021 Merck KGaA Earnings Call TranscriptMay 12, 2021€135.53 (-1.81%)Earnings
- Merck KGaA Annual Shareholders Meeting TranscriptApr 23, 2021
- Full Year 2020 Merck KGaA Earnings Call TranscriptMar 04, 2021€133.2 (+0.68%)Earnings
- Merck KGaA Bintrafusp alfa 037 Ad-Hoc - Capital Markets Q&A Call TranscriptJan 20, 2021
- Merck KGaA at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Merck KGaA at PR Newswire and BetterInvesting (NAIC) Deutsche Bank Depositary Receipts Virtual Investor Conference TranscriptNov 19, 2020
- Q3 2020 Merck KGaA Earnings Call TranscriptNov 12, 2020€130.7 (-0.63%)Earnings
- Merck KGaA CMD - Healthcare:R&D Update Call TranscriptSep 25, 2020
- Merck KGaA Capital Markets Day (virtual) - Performance Materials: Semiconductor Solutions TranscriptSep 16, 2020
- Merck KGaA Capital Markets Day (virtual) - Life Science: Process Solutions TranscriptSep 16, 2020
- Merck KGaA Capital Markets Day (virtual) - CEO/CFO Session and Board Q&A TranscriptSep 16, 2020
- Half Year 2020 Merck KGaA Earnings Call TranscriptAug 06, 2020€113.08 (+1.44%)Earnings
- Merck KGaA Annual Shareholders Meeting TranscriptMay 28, 2020
- Q1 2020 Merck KGaA Earnings Call TranscriptMay 14, 2020€103.25 (-3.14%)Earnings
- Merck KGaA at PR Newswire and BetterInvesting (NAIC) Deutsche Bank Depositary Receipts Virtual Investor Conference TranscriptMar 18, 2020
- Full Year 2019 Merck KGaA Earnings Call TranscriptMar 05, 2020€115.35 (+1.27%)Earnings
- Merck KGaA Evobrutinib (RMS) Update Call TranscriptFeb 20, 2020
- Merck KGaA at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Q3 2019 Merck KGaA Earnings Call TranscriptNov 14, 2019€106.03 (-3.39%)Earnings
- Merck KGaA Capital Market Day TranscriptSep 11, 2019
- Half Year 2019 Merck KGaA Earnings Call TranscriptAug 08, 2019€94.38 (+1.66%)Earnings
- Merck KGaA R&D Update Call TranscriptJun 14, 2019
- Oncolytics Biotech Inc. - Shareholder/Analyst Call TranscriptJun 05, 2019
- Q1 2019 Merck KGaA Earnings Call TranscriptMay 14, 2019€92.09 (-3.55%)Earnings
- Merck KGaA Annual Shareholders Meeting TranscriptApr 26, 2019
- Merck KGaA Signs Definitive Agreement to Acquire Versum Materials Call TranscriptApr 12, 2019
- Merck KGaA FDA Approval of MAVENCLAD Conference Call TranscriptApr 01, 2019
- Full Year 2018 Merck KGaA Earnings Call TranscriptMar 07, 2019€93.23 (-0.03%)Earnings
Q3 2021 Merck KGaA Earnings Call Transcript
Dear ladies and gentlemen, welcome to the Merck Investor and Analyst Conference Call on the third quarter 2021. (Operator Instructions)
We now hand you over to Mr. Constantin Fest, Head of Investor Relations, who will lead you to today's conference. Please go ahead, sir.
Thank you, Tracy. Very warm welcome, dear ladies and gentlemen, to this Q3 2021 results call. My name is Constantin Fest. I'm Head of Investor Relations here at Merck. And I'm delighted to have here with me today, Belen Garijo, Group CEO; as well as Marcus Kuhnert, Group CFO. Also joining for the Q&A of this session today are Matthias Heinzel, CEO of Life Science; as well as Peter Guenter, CEO of Healthcare; and Kai Beckmann, CEO of Electronics.
In the next few minutes, we'd like to run you through the key slides of this presentation and then directly start the Q&A. Having said this, I'd like to now hand over to Belen to kick off the presentation. Over to you, Belen.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)